ADMA vs AMZN · P/E 22, rev $238.9M vs P/E 31, rev $716.92B
ADMA Biologics Inc (ADMA) versus Amazon.com Inc (AMZN) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
Amazon.com Inc (AMZN) is a internet retail company listed on NASDAQ. It is led by Andrew R. Jassy.
Latest reported ADMA revenue for 2026-06-30 was $238.9M. Net income was $83.2M. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Latest reported AMZN revenue for 2025-12-31 was $716.92B. Net income was $77.67B. Revenue was up 12.4% from 2024-12-31 to 2025-12-31. AMZN currently screens at market cap $2.55T and trailing P/E 30.6.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9. AMZN currently screens at market cap $2.55T and trailing P/E 30.6.
Not investment advice. Open the ADMA and AMZN stock pages for the full models.
Not investment advice.